TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $634,000 | -54.1% | 23,600 | +13.5% | 0.00% | -50.0% |
| Q3 2021 | $1,382,000 | -84.0% | 20,800 | -81.2% | 0.00% | -82.6% |
| Q2 2021 | $8,645,000 | -21.9% | 110,800 | -5.3% | 0.02% | -23.3% |
| Q1 2021 | $11,067,000 | -6.3% | 117,000 | +20.7% | 0.03% | -6.2% |
| Q4 2020 | $11,807,000 | +298.6% | 96,900 | +185.8% | 0.03% | +300.0% |
| Q3 2020 | $2,962,000 | +107.6% | 33,900 | +53.4% | 0.01% | +100.0% |
| Q2 2020 | $1,427,000 | – | 22,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |